Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03107897 · ClinicalTrials.gov registry record · NA
Prehabilitation for Patients Undergoing Transcatheter Aortic Valve Replacement
A NA study of Aortic Valve Stenosis, sponsored by WellSpan Health.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT03107897 is a NA study of Aortic Valve Stenosis that has completed, run by WellSpan Health. The registered enrollment target is 35 participants, below the 1,042-participant average among 30 other Aortic Valve Stenosis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03107897, a NA study of Aortic Valve Stenosis, has completed, sponsored by WellSpan Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
In this pilot study, investigators aim to identify patients undergoing TAVR who are at elevated risk for adverse clinical events due to decreased exertional capacity and physical deconditioning. Investigators aim to determine if monitored pre-procedural physical therapy is safe in these patients. Lastly, investigators aim to assess the efficacy of prehabilitation 1. to improve physical functioning by the time of TAVR and to sustain benefit through 30 days post-procedure; and 2. to determine its effect on post-procedural length-of-stay, clinical outcomes, and quality of life.
Conditions Studied
Interventions
- OTHER Pre-habilitation
Study Locations (1)
Pennsylvania
- Wellspan York Hospital - York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2016-08-17 |
| Est. Completion | 2021-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03107897
The ClinicalTrials.gov registry entry for NCT03107897 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,042-participant average among 30 other Aortic Valve Stenosis trials with a reported enrollment target (97% lower). The listed sponsor is WellSpan Health, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Aortic Valve Stenosis appearing as the primary indexed condition, and to 1 intervention - of which Pre-habilitation is the first listed.
NCT03107897 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03107897 about?
NCT03107897 is a clinical study titled "Prehabilitation for Patients Undergoing Transcatheter Aortic Valve Replacement". In this pilot study, investigators aim to identify patients undergoing TAVR who are at elevated risk for adverse clinical events due to decreased exertional capacity and physical deconditioning. Investigators aim to determine if monitored pre-procedural physical therapy is safe in these patients. La...
What is the current status of trial NCT03107897?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2016-08-17. Estimated completion is 2021-04-30.
What conditions does trial NCT03107897 study?
This clinical trial studies the following conditions: Aortic Valve Stenosis.
What interventions are being tested in trial NCT03107897?
The interventions under investigation include: Pre-habilitation (OTHER).
Who is sponsoring clinical trial NCT03107897?
This trial is sponsored by WellSpan Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03107897 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Valve Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Imaging Histone Deacetylase in the Heart
RECRUITING · NA
-
MRI in Transcatheter Aortic Valve Replacement Patients
RECRUITING · NA
-
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
RECRUITING · NA
-
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
RECRUITING · NA
-
Bicuspid Aortic Valve Replacement: Evaluation of Transcatheter Versus Surgery-Pilot Trial
RECRUITING · NA
-
CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.